Nxera Pharma Co Ltd (FRA:JSS)
€ 8.75 -0.3 (-3.31%) Market Cap: 793.19 Mil Enterprise Value: 946.53 Mil PE Ratio: 0 PB Ratio: 2.12 GF Score: 66/100

Q2 2021 Sosei Group Corp Earnings Call Transcript

Aug 12, 2021 / 08:00AM GMT
Release Date Price: €11.7 (-1.68%)
Hironoshin Nomura
Sosei Group Corporation - SVP of IR & Corporate Strategy

[Interpreted] Good afternoon, everyone. We'd like to start the Explanation Session for the Financial Results of First Half of Fiscal Year 2021 for Sosei Group Corporation. Thank you very much for joining us today despite your busy schedule. I am from IR and Corporate Strategy, my name is Nomura. I'll be the moderator for today.

The first 30 minutes, we'd like to give you a presentation, and the latter 30 minutes we'll be spending to answer your questions.

In the presentation from Sosei, COO, CFO, Chris Cargill, will talk about the financial results for the first half. CEO, Tamura, will give you business highlights. And Chief Medical Officer, Tim Tasker, will give you a presentation on the muscarinic program.

I'm sorry for the short notice, but the presentation material has been uploaded on our web page. Please go to the Newsroom, IR Information, Presentation and Webcast for the presentation material and refer to the material as we give the presentation.

Today, we are providing

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot